Jonathan W. Lockner

1.4k total citations
17 papers, 678 citations indexed

About

Jonathan W. Lockner is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jonathan W. Lockner has authored 17 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jonathan W. Lockner's work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jonathan W. Lockner is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Jonathan W. Lockner collaborates with scholars based in United States, China and Japan. Jonathan W. Lockner's co-authors include Phil S. Baran, Darryl D. Dixon, Rune Risgaard, Kim D. Janda, Qianghui Zhou, Joel E. Schlosburg, Karen Collins, Paul T. Bremer, George F. Koob and G. Neil Stowe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Jonathan W. Lockner

17 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan W. Lockner United States 12 306 212 102 91 83 17 678
Karen Collins United States 18 315 1.0× 340 1.6× 133 1.3× 178 2.0× 76 0.9× 26 820
Thomas Ryckmans United Kingdom 15 305 1.0× 499 2.4× 102 1.0× 72 0.8× 37 0.4× 29 877
James S. New United States 15 267 0.9× 288 1.4× 122 1.2× 46 0.5× 26 0.3× 30 740
Jianbing Jiang Netherlands 19 449 1.5× 604 2.8× 115 1.1× 39 0.4× 62 0.7× 36 920
Ali Dehghani United States 10 731 2.4× 523 2.5× 151 1.5× 100 1.1× 425 5.1× 14 1.4k
Joseline Ratnam United States 11 128 0.4× 153 0.7× 79 0.8× 65 0.7× 129 1.6× 11 462
Agostino Bruno Italy 18 154 0.5× 453 2.1× 118 1.2× 73 0.8× 61 0.7× 35 715
Atsushi Kimishima Japan 11 111 0.4× 113 0.5× 82 0.8× 114 1.3× 35 0.4× 27 387
Scott E. Lazerwith United States 11 248 0.8× 362 1.7× 148 1.5× 465 5.1× 77 0.9× 14 1.1k
Samuel W. Gerritz United States 16 319 1.0× 439 2.1× 192 1.9× 76 0.8× 80 1.0× 38 820

Countries citing papers authored by Jonathan W. Lockner

Since Specialization
Citations

This map shows the geographic impact of Jonathan W. Lockner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Lockner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Lockner more than expected).

Fields of papers citing papers by Jonathan W. Lockner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan W. Lockner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Lockner. The network helps show where Jonathan W. Lockner may publish in the future.

Co-authorship network of co-authors of Jonathan W. Lockner

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Lockner. A scholar is included among the top collaborators of Jonathan W. Lockner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Lockner. Jonathan W. Lockner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Staples, Miranda C., Melissa A. Herman, Jonathan W. Lockner, et al.. (2021). Isoxazole‐9 reduces enhanced fear responses and retrieval in ethanol‐dependent male rats. Journal of Neuroscience Research. 99(11). 3047–3065. 5 indexed citations
2.
Castro, Claudia, Alex Blacutt, M. Caroline Roper, et al.. (2020). Synthesis of Deoxyradicinin, an Inhibitor of Xylella fastidiosa and Liberibacter crescens, a Culturable Surrogate for Candidatus Liberibacter asiaticus. Journal of Natural Products. 83(6). 1810–1816. 7 indexed citations
3.
Harbut, Michael B., Baiyuan Yang, Renhe Liu, et al.. (2018). Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angewandte Chemie International Edition. 57(13). 3478–3482. 51 indexed citations
4.
Harbut, Michael B., Baiyuan Yang, Renhe Liu, et al.. (2018). Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angewandte Chemie. 130(13). 3536–3540. 6 indexed citations
5.
Lockner, Jonathan W., Miranda C. Staples, Sucharita S. Somkuwar, et al.. (2017). A synthetic small-molecule Isoxazole-9 protects against methamphetamine relapse. Molecular Psychiatry. 23(3). 629–638. 23 indexed citations
6.
Kimishima, Atsushi, Bin Zhou, Karen Collins, et al.. (2017). A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior. Chemical Communications. 53(58). 8156–8159. 6 indexed citations
7.
Lockner, Jonathan W., et al.. (2016). Investigations of Enantiopure Nicotine Haptens Using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development. Journal of Medicinal Chemistry. 59(6). 2523–2529. 16 indexed citations
8.
Lockner, Jonathan W., et al.. (2014). Pharmacophore Reassignment for Induction of the Immunosurveillance Cytokine TRAIL. Angewandte Chemie International Edition. 53(26). 6628–6631. 29 indexed citations
9.
Lockner, Jonathan W., et al.. (2014). Pharmacophore Reassignment for Induction of the Immunosurveillance Cytokine TRAIL. Angewandte Chemie. 126(26). 6746–6749. 7 indexed citations
10.
Lockner, Jonathan W., Lisa M. Eubanks, Jennifer L. Choi, et al.. (2014). Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development. Molecular Pharmaceutics. 12(2). 653–662. 46 indexed citations
11.
Lockner, Jonathan W., et al.. (2014). A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity. Journal of Medicinal Chemistry. 58(2). 1005–1011. 29 indexed citations
12.
Collins, Karen, Joel E. Schlosburg, Jonathan W. Lockner, et al.. (2014). Lipid tucaresol as an adjuvant for methamphetamine vaccine development. Chemical Communications. 50(31). 4079–4081. 23 indexed citations
13.
Schlosburg, Joel E., Leandro F. Vendruscolo, Paul T. Bremer, et al.. (2013). Dynamic vaccine blocks relapse to compulsive intake of heroin. Proceedings of the National Academy of Sciences. 110(22). 9036–9041. 85 indexed citations
14.
Lockner, Jonathan W., et al.. (2012). Enhancing nicotine vaccine immunogenicity with liposomes. Bioorganic & Medicinal Chemistry Letters. 23(4). 975–978. 28 indexed citations
15.
Dixon, Darryl D., Jonathan W. Lockner, Qianghui Zhou, & Phil S. Baran. (2012). Scalable, Divergent Synthesis of Meroterpenoids via “Borono-sclareolide”. Journal of the American Chemical Society. 134(20). 8432–8435. 125 indexed citations
16.
Lockner, Jonathan W., Darryl D. Dixon, Rune Risgaard, & Phil S. Baran. (2011). Practical Radical Cyclizations with Arylboronic Acids and Trifluoroborates. Organic Letters. 13(20). 5628–5631. 159 indexed citations
17.
Lockner, Jonathan W., et al.. (2002). Regio- and Stereoselectivity of Diethylaluminum Azide Opening of Trisubstituted Epoxides and Conversion of the 3° Azidohydrin Adducts to Isoprenoid Aziridines. The Journal of Organic Chemistry. 68(1). 75–82. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Collins Breakdown of academic impact, for papers by Thomas Ryckmans Breakdown of academic impact, for papers by James S. New Breakdown of academic impact, for papers by Jianbing Jiang Breakdown of academic impact, for papers by Ali Dehghani Breakdown of academic impact, for papers by Joseline Ratnam Breakdown of academic impact, for papers by Agostino Bruno Breakdown of academic impact, for papers by Atsushi Kimishima Breakdown of academic impact, for papers by Scott E. Lazerwith Breakdown of academic impact, for papers by Samuel W. Gerritz
Rankless by CCL
2026